Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Business News › SpeeDx, UgenTec Collaborate on Interpretation for Infectious Disease Dx Results

SpeeDx, UgenTec Collaborate on Interpretation for Infectious Disease Dx Results

Jan 16, 2017
|
staff reporter

NEW YORK (GenomeWeb) – Australian diagnostics firm SpeeDx has announced that Belgian software maker UgenTec will provide interpretation for results generated by the firm's infectious disease diagnostics.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Jul
15
Featured Webinar

Diagnostic Challenges in Cancer Immunotherapy: An Expert Panel Discussion

Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.

What's Popular?

In Molecular Diagnostics

  1. Labs Launching Employer SARS-CoV-2 Testing Programs as Businesses Reopen

    Premium

  2. HHS Releases Data Reporting Guidance for Labs Performing SARS-CoV-2 Testing

  3. CDC Develops Test for Simultaneous Detection of COVID-19, Flu

  4. Beset by COVID-19 Pandemic, Europe Searches for Right Test Mix for Diagnosis, Surveillance

    Premium

  5. Roche Garners FDA Emergency Use Authorization for Elecsys IL-6 Test in COVID-19 Patients

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.